Notably, In the GSE17536 and GSE17537 cohorts, which included 177 and 55 colorectal cancer samples respectively, high GNG7 expression was associated with better OS (p = 0.034, HR = 0.08,95%CI 0.01–0.83) and DSS (Disease Specific Survival, p = 0.031, HR = 0.28,95%CI 0.09–0.89). The gene discussed is GNG7; the disease is colorectal cancer.